Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study https://t.co/TGDxHKqRoP #JMedGenet
91 followers
3,600 followers
RT @Info_Rares: Head-to-head #pegunigalsidase alfa Vs agalsidase beta in #Fabry disease #BALANCE study 👥 77 Pts,18–60y,61%♂️ 🧪Median eGFR:…
2,107 followers
Head-to-head #pegunigalsidase alfa Vs agalsidase beta in #Fabry disease #BALANCE study 👥 77 Pts,18–60y,61%♂️ 🧪Median eGFR: 74.5 mL/min 💉Randomly assigned 2:1 every 2w for 2y 📉Pegunigalsidase:non-inferior to agalsidase on eGFR↘️ 🌡️Similar adverse events htt
2,589 followers
Open Access UCL Research: Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study https://t.co/WsKgcCpubK